Cytosorbents (NASDAQ: CTSO) reported Q4 FY18 of ($0.56), versus ($0.32) reported last year. Revenue for the year came in at $22.5 million, versus $15.15 million reported last year.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.